This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (August 2020) |
Formerly | Applied Molecular Genetics (1980–1983) |
---|---|
Company type | Public |
ISIN | US0311621009 |
Industry | Biotechnology |
Founded | April 8, 1980 |
Headquarters | Thousand Oaks, California, U.S. |
Key people | Robert A. Bradway (chairman, president & CEO) |
Products | |
Revenue | US$28.19 billion (2023) |
US$7.897 billion (2023) | |
US$6.717 billion (2023) | |
Total assets | US$97.15 billion (2023) |
Total equity | US$6.232 billion (2023) |
Number of employees | c. 26,700 (2023) |
Website | amgen |
Footnotes / references [1][2] |
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.[3][4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.[5]
The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its initial public offering).